Taro Pharmaceutical launches generic Deferiprone in U.S.

Sep. 28, 2020 2:09 PM ETTaro Pharmaceutical Industries Ltd. (TARO)By: Meghavi Singh, SA News Editor
  • Taro Pharmaceutical (NYSE:TARO -0.5%) has announced the launch of deferiprone, a generic version of Chiesi's Ferriprox, an iron chelator indicated for transfusional iron overload due to thalassemia syndromes, when current chelation therapy is not sufficient.
  • The company will team up with BioPlus Specialty Pharmacy for distribution of deferiprone tablets at launch.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.